Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback